Defense

Chem-Bio Defense

Identify bio agents & determine toxicity within minutes

Impossible? Not to Us.

Our bioassays determine whether potentially harmful substances are present. But most importantly, they determine toxicity in a matter of minutes – not days – which makes all the difference in life or death situations.

Acumen Detection, LLC, an SRC company, has developed patented bioassays that detect biologically active toxins such as Botulinum Neurotoxin (BoNT), Ricin and Staphylococcal Enterotoxin B (SEB).

These bioassays work on the same Polymerase Chain Reaction (PCR) platforms used to identify bacterial and viral targets. This not only reduces the amount of equipment required to identify the full spectrum of biological terrorism agents, it also provides a critical piece of information for decision makers on-the-spot. 

Simple is better

We developed a chemistry with the sensitivity and specificity of PCR based technology, but without PCR’s susceptibility to common environmental interferents like salts. By making assays tolerant of interferents, it eliminates the need for costly and time-consuming sample clean-up. This helps simplify and accelerate the overall time to go from sample collection to resulting identification. 

Knowing is everything, unless it's too late

Knowing whether a toxin is still a hazard, or if it has been degraded to a benign state, is critical information to have in time-sensitive situations. The quicker this information can be determined, the quicker a decision can be made on protecting potentially exposed people.

Our bioassays determine whether the toxin is biologically active and therefore hazardous in near real-time, which makes all the difference in a matter of life or death decisions.

Learn more about how the bioassays produced by Acumen Detection, LLC are redefining possible®.